Literature DB >> 10962578

Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.

N Rahman1, M D Teare, S Seal, H Renard, J Mangion, C Cour, D Thompson, Y Shugart, D Eccles, P Devilee, H Meijers, K L Nathanson, S L Neuhausen, B Weber, J Chang-Claude, D F Easton, D Goldgar, M R Stratton.   

Abstract

Several recent studies indicate that the majority of families with five or fewer cases of breast cancer and no cases of ovarian cancer are not due to BRCA1 or BRCA2. It has been proposed that a further breast cancer susceptibility gene that may account for some of these families is located on chromosome 8p12-p22. We have identified 31 site-specific breast cancer families that have a greater than 80% posterior probability of being due to genes other than BRCA1 or BRCA2. These families have been examined for linkage to 8p12-p22 using markers flanking the putative location of the gene. The overall multi-point LOD score is strongly negative across the whole 44 cM. The individual multi-point LOD score is negative in 23 families and only exceeds 0.5 in a single family (with a multi-point LOD score of 1.22). The maximum heterogeneity LOD score was 0.03 at marker D8S136 with estimated proportion linked (alpha) of 3% (95% CI 0 - 30%). These data do not lend support to the hypothesis that chromosome 8p12-p22 harbours a familial breast cancer susceptibility gene. Oncogene (2000) 19, 4170 - 4173

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962578     DOI: 10.1038/sj.onc.1203735

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.

Authors:  Bert Gold; Tomas Kirchhoff; Stefan Stefanov; James Lautenberger; Agnes Viale; Judy Garber; Eitan Friedman; Steven Narod; Adam B Olshen; Peter Gregersen; Kristi Kosarin; Adam Olsh; Julie Bergeron; Nathan A Ellis; Robert J Klein; Andrew G Clark; Larry Norton; Michael Dean; Jeff Boyd; Kenneth Offit
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

2.  BAP1 and breast cancer risk.

Authors:  Isabelle Coupier; Pierre-Yves Cousin; David Hughes; Patricia Legoix-Né; Alexandra Trehin; Olga M Sinilnikova; Dominique Stoppa-Lyonnet
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.

Authors:  Deborah Thompson; Csilla I Szabo; Jon Mangion; Rogier A Oldenburg; Fabrice Odefrey; Sheila Seal; Rita Barfoot; Karin Kroeze-Jansema; Dawn Teare; Nazneen Rahman; Hélène Renard; Graham Mann; John L Hopper; Saundra S Buys; Irene L Andrulis; Ruby Senie; Mary B Daly; Dee West; Elaine A Ostrander; Ken Offit; Tamar Peretz; Ana Osorio; J Benitez; Katherine L Nathanson; Olga M Sinilnikova; Edith Olàh; Yves-Jean Bignon; Pablo Ruiz; Michael D Badzioch; Hans F A Vasen; Andrew P Futreal; Catherine M Phelan; Steven A Narod; Henry T Lynch; Bruce A J Ponder; Ros A Eeles; Hanne Meijers-Heijboer; Dominique Stoppa-Lyonnet; Fergus J Couch; Diana M Eccles; D Gareth Evans; Jenny Chang-Claude; Gilbert Lenoir; Barbara L Weber; Peter Devilee; Douglas F Easton; David E Goldgar; Michael R Stratton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

Review 4.  The genetic epidemiology of breast cancer genes.

Authors:  Deborah Thompson; Douglas Easton
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

5.  Molecular classification of familial non-BRCA1/BRCA2 breast cancer.

Authors:  Ingrid Hedenfalk; Markus Ringner; Amir Ben-Dor; Zohar Yakhini; Yidong Chen; Gunilla Chebil; Robert Ach; Niklas Loman; Håkan Olsson; Paul Meltzer; Ake Borg; Jeffrey Trent
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-27       Impact factor: 11.205

Review 6.  BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

Authors:  Olga M Sinilnikova; Sylvie Mazoyer; Colette Bonnardel; Henry T Lynch; Steven A Narod; Gilbert M Lenoir
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

7.  A genome wide linkage search for breast cancer susceptibility genes.

Authors:  Paula Smith; Lesley McGuffog; Douglas F Easton; Graham J Mann; Gulietta M Pupo; Beth Newman; Georgia Chenevix-Trench; Csilla Szabo; Melissa Southey; Hélène Renard; Fabrice Odefrey; Henry Lynch; Dominique Stoppa-Lyonnet; Fergus Couch; John L Hopper; Graham G Giles; Margaret R E McCredie; Saundra Buys; Irene Andrulis; Ruby Senie; David E Goldgar; Rogier Oldenburg; Karin Kroeze-Jansema; Jaennelle Kraan; Hanne Meijers-Heijboer; Jan G M Klijn; Christi van Asperen; Inge van Leeuwen; Hans F A Vasen; Cees J Cornelisse; Peter Devilee; Linda Baskcomb; Sheila Seal; Rita Barfoot; Jon Mangion; Anita Hall; Sarah Edkins; Elizabeth Rapley; Richard Wooster; Jenny Chang-Claude; Diana Eccles; D Gareth Evans; P Andrew Futreal; Katherine L Nathanson; Barbara L Weber; Nazneen Rahman; Michael R Stratton
Journal:  Genes Chromosomes Cancer       Date:  2006-07       Impact factor: 5.006

8.  Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population.

Authors:  Paula Silva Felicio; Lucas Tadeu Bidinotto; Matias Eliseo Melendez; Rebeca Silveira Grasel; Natalia Campacci; Henrique C R Galvão; Cristovam Scapulatempo-Neto; Rozany Mucha Dufloth; Adriane Feijó Evangelista; Edenir Inêz Palmero
Journal:  Oncotarget       Date:  2018-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.